Suppr超能文献

糖尿病患者玻璃体内注射的并发症

Complications of Intravitreous Injections in Patients with Diabetes.

作者信息

Gupta Aditi, Sun Jennifer K, Silva Paolo S

机构信息

a Beetham Eye Institute, Joslin Diabetes Center , Boston , MA , USA.

b Department of Ophthalmology , Harvard Medical School , Boston , MA , USA.

出版信息

Semin Ophthalmol. 2018;33(1):42-50. doi: 10.1080/08820538.2017.1353811.

Abstract

Intravitreous injections are presently the second most frequently performed ophthalmic procedure and the most common vitreoretinal procedure. In diabetic patients, intravitreous injections are frequently performed for the treatment of center-involved diabetic macular edema, proliferative diabetic retinopathy, or other co-existing retinal vascular disease. Diabetic patients may be at higher risk of adverse events compared to non-diabetic individuals, given frequent systemic comorbidities, such as cardiovascular and renal disease and increased susceptibility to infection. This review highlights the potential complications and safety considerations in intravitreous injections in patients with diabetes.

摘要

玻璃体内注射目前是第二常见的眼科手术,也是最常见的玻璃体视网膜手术。在糖尿病患者中,玻璃体内注射常用于治疗累及黄斑中心的糖尿病性黄斑水肿、增殖性糖尿病视网膜病变或其他并存的视网膜血管疾病。鉴于糖尿病患者常伴有心血管疾病和肾脏疾病等全身性合并症,且感染易感性增加,与非糖尿病个体相比,他们发生不良事件的风险可能更高。本综述重点介绍了糖尿病患者玻璃体内注射的潜在并发症和安全注意事项。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验